These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18028997)

  • 1. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis.
    Casale TB; Romero FA; Spierings EL
    J Allergy Clin Immunol; 2008 Jan; 121(1):105-9. PubMed ID: 18028997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal carbon dioxide for the symptomatic treatment of perennial allergic rhinitis.
    Casale TB; Korenblat PE; Meltzer EO; Yen K; Bhatnagar A
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):364-70. PubMed ID: 21962098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI; Levy AL; Hampel FC; Baidoo CA; Cook CK; Philpot EE; Rickard KA
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal Carbon Dioxide Used As Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis.
    Casale TB; Onder RF; Berkowitz RB; Korenblat PE
    J Allergy Clin Immunol Pract; 2018; 6(1):183-189. PubMed ID: 28705451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P; Zieglmayer R; Bareille P; Rousell V; Salmon E; Horak F
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
    Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model.
    Day JH; Briscoe MP; Rafeiro E; Ellis AK; Pettersson E; Akerlund A
    J Allergy Clin Immunol; 2000 Mar; 105(3):489-94. PubMed ID: 10719298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment.
    Meltzer EO; Berkowitz RB; Grossbard EB
    J Allergy Clin Immunol; 2005 Apr; 115(4):791-6. PubMed ID: 15806000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.
    Cordray S; Harjo JB; Miner L
    Ear Nose Throat J; 2005 Jul; 84(7):426-30. PubMed ID: 16813032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, parallel groups, placebo-controlled study of efficacy and safety of Rynatan in the treatment of allergic rhinitis using an acute model.
    Weiler JM; Gellhaus M; Donnelly A; Weiler K
    Ann Allergy; 1990 Jan; 64(1):63-7. PubMed ID: 2404433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.
    Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A
    Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM; Kusma M; Feuring M; Timmer WE; Neuhäuser M; Bethke T; Stuck BA; Hörmann K; Wehling M
    J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.